Podcast Cruzamento André Correia e Daniel Guedelha

In this engaging episode of the new segment Cruzamento Education, hosts André Correia e Daniel Guedelha delve into the world of value-based healthcare with special guest Filipe Costa. They explore the fundamental concepts of value-based healthcare, discussing its importance in delivering meaningful outcomes for patients while optimising costs. Felipe provides insights into the key topics of patient-reported outcome measurements, technology integration, financial incentives alignment, and the role of data interoperability in supporting value-based healthcare initiatives. The conversation highlights Portugal's potential to lead the way in implementing value-based healthcare practices and emphasises the importance of transparency, evidence-based decision-making, and collaboration across the healthcare ecosystem.



Filipe Costa's profile:




Professor in Management & VBHC at Nova SBE Exec. Education



Researcher in Nova Healthcare Economics & Management Knowledge Centre- Coordinated by Prof Pedro Pita Barros



Executive Coordinator of the Pos Graduation of Healthcare Management NOVA SBE Executive Education



Past Director of VBHC in Luz Saúde Group



Post Graduated in Harvard Business School- Value Based Healthcare



MBA and a master in management



Areas of interest and research: value-based health, health management, organizatioal theory, operations management, outcomes, cost analysis, payment models and process improvement.



Led several national and international management projects in VBHC



Distinguished Merit Award the International Federation of Hospitals 2019 in Patient Cantered Care with the Value project Health care based.



Best VBHC Group in Portugal price by Accenture, Jansen, APAH, J. Negocios



Several publications and International presentations about VBHC




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento




Episode edited by João Cunha Studios

In today's CRUZAMENTO Podcast, André Correia e Daniel Guedelha talked with Daniel Lewi, co-founder and CEO of the CATS Foundation, about the world of rare disease advocacy. Dan shares his personal journey as a patient advocate and discusses the mission of the CATS Foundation, which focuses on raising awareness and driving research for Tay-Sachs and Sandhoff disease. He highlights the importance of collaboration and transparency in advocating for better treatment options, emphasising the need for data sharing, especially in drug repurposing efforts. Dan also shares insights into engaging with pharmaceutical companies, emphasising the importance of building trust, clear communication, and collaborative strategies. Throughout the conversation, the critical role of patient voices, diverse perspectives, and community involvement in shaping advocacy efforts is emphasised, ensuring that the needs and experiences of individuals impacted by rare diseases are at the forefront of research and development initiatives.



Dan Lewi's eldest daughter Amelie was diagnosed with Tay-Sachs in 2011 at 15 months of age and upon finding that there was no dedicated advocacy group providing support for families affected by this disease in the UK he set set-up the Cure & Action for Tay-Sachs (CATS) Foundation with his wife Patricia. Since the group was launched, they have been able to grow The CATS Foundation so that it now offers a variety of services to its family members and has been actively involved in the research investigating therapeutic treatments for Tay-Sachs and Sandhoff disease. In addition to this, Dan is the one of the founding members and Chairman of the European Tay-Sachs and Sandhoff Charity Consortium which brings together all the European patient groups leading the fight against the diseases and is part of the team establishing the IGGA, a global organisation bringing together all the advocacy groups for GM1 and GM2. Dan is fully committed to leading the charity towards its goal of finding a treatment so that there is hope for those families affected by Tay-Sachs and Sandhoff in the future



Other relevant references | Outras referências relevantes:




CATS Foundation (website)




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento




Episode edited by João Cunha Studios

Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Cristina Fraga, CEO da mindout, uma Health Startup focada na saúde mental. Nesta conversa, a Cristina partilha a sua transição do mundo corporativo para o empreendedorismo, discutindo a importância do tema da saúde mental nas empresas e na sociedade. Exploramos o impacto do Burnout, a sua prevalência global e consequências económicas, bem como estratégias para identificar e mitigar esta condição nas organizações. Além disso, abordamos desafios na implementação de programas de prevenção, a importância da liderança na quebra do estigma e como a tecnologia pode ser utilizada para melhorar a saúde mental dos colaboradores, especialmente no contexto do trabalho remoto. Por fim, discutimos a relevância de fornecer suporte e ferramentas para estudantes universitários lidarem com estas questões.



Cristina Fraga é Fundadora e CEO da mindout, uma health/brain-tech startup sediada em Lisboa, que opera na área da saúde mental e está disponível para estudantes universitários, trabalhadores e empresas e profissionais de saúde de todo o mundo. Cristina é Engenheira Informática do IST, trabalhou 8 anos na Deloitte, 2 anos na Deloitte PT e 6 anos na Deloitte US nos escritórios de San Francisco e Manhattan, sempre na área da Tecnologia. Voltou para Portugal em 2013 onde esteve 8 anos na EDP, também ligada ao Digital e Marketing Digital. Em 2020 tirou um Executive MBA no INSEAD e juntou-se à Liberty Insurance como Chief Marketing Officer da Europa. Como sempre teve vontade de criar valor na área da saúde, após a saída de um burnout em 2022, decidiu criar a mindout, utilizando a experiência que viveu nessa mesma jornada, o know-how de business management e liderança com o seu lado tecnológico, para criar uma solução escalável e sustentável para prevenção e reversão de burnouts com uma jornada clara e transparente, com grande foco em Inteligência Artificial.



Other relevant references | Outras referências relevantes:




mindout (website)




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento








Episódio editado por João Cunha Studios

In this episode of Cruzamento Podcast, hosts André Correia and Daniel Guedelha explore the intersections of technology, healthcare, and leadership with Alan Triggs, Chief Digital Officer for Nokia. They delve into the impact of AI on industries, discussing the evolution of AI, its role in job creation and displacement, and its potential impact on healthcare and education. Alan shares insights on data management, privacy concerns, and the role of regulation in technology. The discussion extends to the personal experiences, touching on longevity, wellness, and the importance of sleep hygiene in the digital age. Alan also shares experiences from relocating to Portugal and Nokia's investment in the country.
Tune in to explore these topics and more in this insightful episode.



Alan Triggs is the Chief Digital Officer for Nokia globally, with responsibility for Nokia’s information technology (IT) and digitalisation initiatives. In this role, he is responsible for the global infrastructure for enterprise computing, networking, and end-user services, and enterprise applications covering R&D, services, supply, and financial & commercial systems. He is responsible for number of digital transformation initiatives including a company-wide cloud transformation, the modernisation of core application systems, and the corporate data strategy. Alan has held a number of leadership roles in IT; Telecom and has lived and worked in in seven countries across Africa, Europe and the US. He is currently based out of Portugal.



Other relevant references | Outras referências relevantes:




Blueprint (by Bryan Johnson)




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento








Episode edited by João Cunha Studios

Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha dialogam com Luís Oliveira, Senior Associate Director Research Programs na The Michael J. Fox Foundation, abordando a missão inspiradora da fundação, o impacto global das doenças neurodegenerativas em saúde e economia, e estratégias eficazes para mitigar riscos na Doença de Parkinson.



Luis Miguel Oliveira is a Senior Associate Director of Research Programs at The Michael J. Fox Foundation and the Founder of v-ATPase Alliance for rare diseases due to v-ATPase defects.



Luís is an expert in the field of Parkinson's disease research and investment with more than 15 years of experience in the neurologic diseases space. Currently, he holds the position of Senior Associate Director of Research Programs at The Michael J. Fox Foundation, where he leads various efforts for therapeutic and biomarker development in priority genetic targets in Parkinson's disease accounting for over $30 million in executed projects. Additionally, Luis Miguel Oliveira is a founder of the v-ATPase Alliance, an organization aimed at connecting families affected by rare diseases related to v-ATPase with the research and medical communities to further advance therapeutic development.



With a strong commitment to advance novel treatments from the bench to bedside, Luis Miguel Oliveira serves as a Review Editor for Frontiers in Neurology, Neuroscience and Psychiatry, and as an Investment Advisor for Portugal Ventures, where he leverages his expertise to guide investment decisions in promising ventures.



Recently, Luis Miguel Oliveira had an integral contribution to a landmark study that validated the first biomarker for Parkinson's disease diagnosis. This significant achievement was reported in Lancet Neurology with broader international media coverage and is changing the Parkinson's research and drug development fields by enabling an objective characterization of the disease based on its biological features.



Luis Miguel Oliveira's educational background includes a degree in Biochemistry from the Faculty of Sciences of Lisbon University. He further pursued his academic journey with a PhD in Molecular Biophysics from the same institution. During his postdoctoral research experience, he conducted his studies at renowned institutions such as the Max Planck Institute for Biophysical Chemistry in Germany and Columbia University in New York.



Other relevant references | Outras referências relevantes:




v-ATPase Alliance (website)



The Michael J. Fox Foundation (website)




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento

In today's CRUZAMENTO Podcast, André Correia e Daniel Guedelha talked with Stefan Buttigieg, about the impact of AI on healthcare. Highlights include AI's potential in public health, data sharing challenges in Europe, AI projects in Malta, and the importance of equity and ethical data handling in healthcare.



Dr. Stefan Buttigieg is a Specialist in Public Health Medicine working in the Ministry for Health in Malta !🇲🇹
He is a Keynote Speaker with 50+ public speaking engagements track record and an avid content creator!📱🎙️.
He is the manager of the National Contact Point of eHealth and lectures at the University of Malta on the topics of Digital Health, Social Media in Healthcare and Digital Therapeutics.
He is the Vice-President of the EUPHA Section on Digital Health and is a WFPHA Governing Council Member.
Dr Buttigieg is on a mission to enable equitable Digital Health and Health Data for All ensuring that no one is left behind



Other relevant references | Outras referências relevantes:




Stefan Buttigieg (Website)



Yuval Noah Harari argues that AI has hacked the operating system of human civilisation



Yuval Noah Harari at the Frontiers Forum - AI and the future of humanity




Contacts | Contactos:




CruzamentoPodcast.com



cruzamentopodcast@gmail.com



LinkedIN: Cruzamento



Twitter: @cruzamentofm



Facebook: @podcastcruzamento



Instagram: @cruzamentopodcast



YouTube: Podcast Cruzamento